These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 19555401

  • 1. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [Abstract] [Full Text] [Related]

  • 2. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [Abstract] [Full Text] [Related]

  • 3. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [Abstract] [Full Text] [Related]

  • 4. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [Abstract] [Full Text] [Related]

  • 5. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Am J Gastroenterol; 2008 Jun; 103(6):1406-12. PubMed ID: 18510608
    [Abstract] [Full Text] [Related]

  • 6. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P, Sharma BC, Sarin SK.
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Tyagi P, Kumar M, Sarin SK.
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
    Sharma P, Sharma BC, Sarin SK.
    Neurol India; 2010 Feb; 58(2):220-4. PubMed ID: 20508339
    [Abstract] [Full Text] [Related]

  • 9. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC.
    Saudi J Gastroenterol; 2010 Feb; 16(3):181-7. PubMed ID: 20616413
    [Abstract] [Full Text] [Related]

  • 10. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P, Sharma BC, Agrawal A, Sarin SK.
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV, Sharma BC, Sharma P, Sarin SK.
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [Abstract] [Full Text] [Related]

  • 12. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
    [Abstract] [Full Text] [Related]

  • 13. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A, Sharma BC, Sharma P, Sarin SK.
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [Abstract] [Full Text] [Related]

  • 14. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC, Sharma P, Agrawal A, Sarin SK.
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [Abstract] [Full Text] [Related]

  • 15. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L, Sharma BC, Srivastava S, Puri SK, Sharma P, Sarin S.
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [Abstract] [Full Text] [Related]

  • 16. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J, Sharma BC, Puri V, Sachdeva S, Srivastava S.
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [Abstract] [Full Text] [Related]

  • 17. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C, Cauli O, Urios A, ElMlili N, Serra MA, Giner-Duran R, González-Lopez O, Del Olmo JA, Wassel A, Rodrigo JM, Felipo V.
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [Abstract] [Full Text] [Related]

  • 18. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V.
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [Abstract] [Full Text] [Related]

  • 19. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z, Li YY.
    Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1126-9. PubMed ID: 12921628
    [Abstract] [Full Text] [Related]

  • 20. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P, Sharma BC.
    Saudi J Gastroenterol; 2012 Jul 10; 18(3):168-72. PubMed ID: 22626795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.